American Vanguard Co. (NYSE:AVD) Insider Peter Eilers Sells 5,000 Shares

American Vanguard Co. (NYSE:AVDGet Free Report) insider Peter Eilers sold 5,000 shares of the business’s stock in a transaction dated Thursday, August 29th. The stock was sold at an average price of $5.80, for a total transaction of $29,000.00. Following the transaction, the insider now owns 42,905 shares in the company, valued at $248,849. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

American Vanguard Stock Performance

Shares of AVD stock opened at $5.74 on Friday. The company has a market capitalization of $160.49 million, a price-to-earnings ratio of 22.06 and a beta of 0.91. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.12 and a current ratio of 2.29. American Vanguard Co. has a 52 week low of $4.95 and a 52 week high of $14.28. The company has a 50-day simple moving average of $7.78 and a 200 day simple moving average of $9.69.

American Vanguard (NYSE:AVDGet Free Report) last issued its quarterly earnings data on Thursday, August 8th. The basic materials company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.08). The firm had revenue of $128.21 million for the quarter, compared to the consensus estimate of $134.20 million. American Vanguard had a return on equity of 2.20% and a net margin of 1.22%. On average, sell-side analysts predict that American Vanguard Co. will post 0.44 earnings per share for the current year.

American Vanguard Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 10th. Shareholders of record on Wednesday, June 26th were issued a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a yield of 2.09%. The ex-dividend date of this dividend was Wednesday, June 26th. American Vanguard’s dividend payout ratio is 46.15%.

Analyst Ratings Changes

A number of equities analysts have weighed in on AVD shares. Lake Street Capital assumed coverage on American Vanguard in a research report on Monday, July 22nd. They set a “buy” rating and a $14.00 price target on the stock. StockNews.com lowered American Vanguard from a “hold” rating to a “sell” rating in a report on Tuesday, August 13th. One investment analyst has rated the stock with a sell rating and four have issued a buy rating to the company’s stock. According to MarketBeat, American Vanguard presently has an average rating of “Moderate Buy” and an average target price of $16.67.

Read Our Latest Research Report on AVD

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the company. CWM LLC increased its holdings in shares of American Vanguard by 492.4% during the fourth quarter. CWM LLC now owns 2,340 shares of the basic materials company’s stock worth $26,000 after purchasing an additional 1,945 shares during the period. Gladius Capital Management LP acquired a new stake in American Vanguard during the second quarter worth approximately $32,000. Nisa Investment Advisors LLC increased its stake in American Vanguard by 7,554.5% during the 2nd quarter. Nisa Investment Advisors LLC now owns 4,210 shares of the basic materials company’s stock worth $36,000 after acquiring an additional 4,155 shares during the period. Point72 DIFC Ltd raised its holdings in American Vanguard by 195.7% in the 2nd quarter. Point72 DIFC Ltd now owns 5,080 shares of the basic materials company’s stock valued at $44,000 after acquiring an additional 3,362 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC bought a new stake in shares of American Vanguard during the 2nd quarter valued at $118,000. Institutional investors own 79.04% of the company’s stock.

About American Vanguard

(Get Free Report)

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.

Further Reading

Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.